Low-dose aspirin reduces CRC risk by 34% after just 1 y

Access to the full content of this site is available only to registered healthcare professionals. Register to read more

Takeaway

  • Taking low-dose aspirin could reduce the risk for colorectal cancer (CRC) by more than one-third.
  • Decreased risk observed after just 1 y of aspirin therapy for CRC stages B-D, but only in stage A after 5 y of use.

Why this matters

  • Findings offer evidence for starting a low...